These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 29270746)
1. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma. Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746 [TBL] [Abstract][Full Text] [Related]
2. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma. Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases. Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644 [TBL] [Abstract][Full Text] [Related]
5. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921 [TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293 [TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed. Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157 [TBL] [Abstract][Full Text] [Related]
9. Characterization of CD133+ parenchymal cells in the liver: histology and culture. Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219 [TBL] [Abstract][Full Text] [Related]
10. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683 [TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype. Terada T Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322 [TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan. Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199 [No Abstract] [Full Text] [Related]
13. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases]. Xu J; Zhang C; Qiao A; Xi Y Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962 [TBL] [Abstract][Full Text] [Related]
15. Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver. Tsuneyama K; Kaizaki Y; Doden K; Kidani E; Harada K; Sasaki M; Nakanuma Y Pathol Int; 2003 Feb; 53(2):90-7. PubMed ID: 12588436 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of combined hepatic carcinoma]. He C; Yin HF; Liu P; Zhang Y; Zhang JB Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101 [TBL] [Abstract][Full Text] [Related]
17. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance. Sasaki M; Sato Y; Nakanuma Y Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. Lee CH; Hsieh SY; Chang CJ; Lin YJ J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166 [TBL] [Abstract][Full Text] [Related]
20. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma. Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918 [No Abstract] [Full Text] [Related] [Next] [New Search]